EUVIMEDEUVIMED entdecken
Crossref

Developmental uterovaginal anomalies and histologic findings in transgender patients receiving gender‐affirming hysterectomies: A large case series

Nghiem H Nguyen iD, Hoejeong Kim, Christina Tran, Megan Sumida, Elisa Lansdowne, Rosanna Galzote-Carino

International Journal of Gynecology & Obstetrics · 2024

DOI: 10.1002/ijgo.15582 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, 2024. Verfasst von Nghiem H Nguyen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California, USA. Hauptthemen laut MEDLINE: Hysterectomy, Transgender Persons, Uterus, Vagina. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To describe the incidence of uterovaginal anomalies and histologic findings in transgender and nonbinary (TGNB) patients seeking hysterectomies.

Methods

All patients receiving gender‐affirming hysterectomies between 2013 and 2023 were retrospectively reviewed. Primary outcomes included uterovaginal anomalies and histological findings. Multivariable logistic regressions were performed to evaluate relationships between variables of interest and whether they predict findings of uterovaginal anomalies, inactive endometrium, adenomyosis, leiomyoma, endometriosis, and cervical atrophy.

Results

278 patients received hysterectomies at an average age of 29.2 ± 8.3 years. Seven patients (2.5%) were found to have a developmental anomaly, including two bicornuate uterus (0.7%), two unicornuate uterus (0.7%), one septate uterus (0.4%), and two vaginal septum (0.7%). 60 patients (21.6%) were found to have inactive endometrium and 26 patients (9.4%) had cervical atrophy. Although 262 patients (94.2%) were on testosterone therapy, hormone duration was not a significant predictor of any uterine findings.

Conclusion

This study describes uterovaginal anomalies in a large cohort of patients receiving gender‐affirming hysterectomies. Although long‐term testosterone use is commonly believed to be associated with endometrial and cervical atrophy, this study shows no such association.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HysterectomyTransgender PersonsUterusVaginaHumansFemaleAdultRetrospective StudiesMaleYoung AdultMiddle AgedLogistic Models

Stichwörter der Autor:innen

gender‐affirminghormone therapyhysterectomytestosteronetransgenderuterovaginal anomalies

Autor:innen und Institutionen

  • Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California, USA.
  • Department of Obstetrics and Gynecology, Kaiser Permanente Southern California Medical Group, Los Angeles, California, USA.

ORCID-Profile: Nghiem H Nguyen

Zitieren

APA

Nguyen, N. H., Kim, H., Tran, C., Sumida, M., Lansdowne, E., & Galzote-Carino, R. (2024). Developmental uterovaginal anomalies and histologic findings in transgender patients receiving gender‐affirming hysterectomies: A large case series. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.15582

Vancouver

Nguyen NH, Kim H, Tran C, Sumida M, Lansdowne E, Galzote-Carino R. Developmental uterovaginal anomalies and histologic findings in transgender patients receiving gender‐affirming hysterectomies: A large case series. International Journal of Gynecology & Obstetrics. 2024. doi:10.1002/ijgo.15582

BibTeX
@article{Nguyen2024,
  author = {Nguyen, Nghiem H and Kim, Hoejeong and Tran, Christina and Sumida, Megan and Lansdowne, Elisa and Galzote-Carino, Rosanna},
  title = {Developmental uterovaginal anomalies and histologic findings in transgender patients receiving gender‐affirming hysterectomies: A large case series},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2024},
  doi = {10.1002/ijgo.15582}
}
Kostenlos starten →